Previous studies using animal models indicated that FABP4 plays a significant role in several aspects of metabolic syndrome, including insulin resistance, type 2 diabetes, and atherosclerosis, through its action at the interface of metabolic and inflammatory pathways in adipocytes and macrophages [33]–[36]. The gene discussed is FABP4; the disease is Insulin resistance.